This vaccine consists of irradiated whole tumor cells (rWTC) with Mannan-BAM, toll-like receptor (TLR) agonists (LTA, PolyI:C, and Resiquimod) and an anti-CD40 monoclonal Antibody (mAb). The gene discussed is CD40; the disease is neoplasm.